Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Lymphoma × Palliative Care × Clear all

Status

Sponsor Class

Study Type

Interventional 5 Observational 1

Sponsor

Cancer Type

Conditions

Neoplasms 4 Pancreatic Neoplasms 2 Pulmonary Disease, Chronic Obstructive 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Penile Neoplasms 1 Oropharyngeal Neoplasms 1 Lymphoma 1 Leukemia 1 Kidney Failure, Chronic 1 Idiopathic Pulmonary Fibrosis 1 Glioblastoma 1 Cholangiocarcinoma 1 Carcinoma 1

Interventions

Gene Expression Profiling 10 Polymerase Chain Reaction 8 Amplified Fragment Length Polymorphism Analysis 8 Surveys and Questionnaires 7 Immunohistochemistry 7 Flow Cytometry 7 Microarray Analysis 6 Interviews as Topic 4 Rituximab 3 Psychiatric Rehabilitation 3 Immunologic Techniques 3 Gene Rearrangement 3 Data Collection 3 Cytogenetic Analysis 3 Biopsy 3 plerixafor 2 Therapeutics 2 Positron-Emission Tomography 2 Phlebotomy 2 Pharmacogenomic Testing 2 Observation 2 Mental Status and Dementia Tests 2 Magnetic Resonance Spectroscopy 2 Leukapheresis 2 Lenalidomide 2 In Situ Hybridization, Fluorescence 2 Hematologic Tests 2 Focus Groups 2 Drug Therapy 2 Doxorubicin 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07032103 2025-06-22

SMCLYM-IV

Samsung Medical Center

Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡